查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1951704

2026年全球诊断酵素市场报告

Diagnostic Enzyme Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，诊断酵素市场成长显着，预计到2025年将达到44.9亿美元，到2026年将达到47.5亿美元，复合年增长率为5.7%。过去几年成长要素包括高纯度诊断酶供应有限、对传统检测方法的依赖、慢性病发病率上升、生物技术和研究活动的扩展以及人们对基于酶的诊断方法的认识不断提高。

预计未来几年，诊断酵素市场将维持强劲成长，到2030年市场规模将达到63.9亿美元，复合年增长率（CAGR）为7.7%。预测期内的成长要素包括：先进酵素工程技术的开发、诊断技术与数位健康平台的整合、就地检验（POC​​T）的日益普及、製药和生物技术领域研发投入的增加，以及政府和私人对诊断创新投入的不断增长。预测期内的主要趋势包括：酶基诊断试剂盒的广泛应用、个人化医疗和生物标记检测的发展、研究和生物技术应用的不断拓展、对高特异性和高灵敏度酶的需求不断增长，以及酶诊断技术在就地检验中的应用。

预计未来几年，慢性病盛行率的不断上升将推动诊断酶市场的成长。慢性病是指持续超过三个月的长期健康状况。诊断酶在慢性病和其他疾病的诊断和持续监测中发挥关键作用，它能够帮助医疗专业人员评估疾病严重程度、追踪治疗效果，并对治疗方案进行合理的调整。例如，根据美国国家医学图书馆截至2023年1月的数据，预计到2050年，美国50岁及以上至少有一种慢性病的人口数量将增加99.5%，从7152.2万人增加至1.4266亿人。因此，慢性病负担的加重正在推动诊断酶市场的扩张。

为了满足临床诊断（尤其是肿瘤和传染病检查）对高灵敏度和绝对定量日益增长的需求，诊断酶市场的主要企业正日益关注数位PCR平台等技术创新。数位PCR (dPCR) 技术将样本分割成数千个奈米升级反应，无需标准曲线即可对目标核酸进行精确的绝对定量。与依赖参考标准且可能缺乏低浓度目标精确度的传统定量PCR不同，dPCR具有更高的准确性。例如，2024年9月，总部位于德国的生技公司凯杰(QIAGEN NV)宣布推出其临床级dPCR平台－QIAcuityDx数位PCR系统。该系统将分割、热循环和成像整合于单一自动化设备中，可对DNA和RNA进行精确定量，适用于液态生物检体等癌症监测应用。该平台已获得欧洲体外诊断医疗器材法规 (IVDR) 认证、美国 510(k) 豁免，并配备直觉易用的软体、灵活的排程安排，以及透过 GeneGlobe 平台提供的伴随诊断开发支援。 QIAcuityDx 系统透过减少人工干预来提高实验室效率，即使在目标分子浓度较低的情况下也能提供一致可靠的结果。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球诊断酵素市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 酵素法诊断试剂盒的广泛应用
    • 个人化医疗和生物标记发现的发展
    • 拓展研究与生物技术应用
    • 对高特异性和高灵敏度酵素的需求日益增长
    • 将酵素诊断技术整合到即时检测中

第五章 终端用户产业市场分析

  • 製药公司
  • 研究所
  • 生技公司
  • 医院和诊断中心
  • 学术和临床研究机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球诊断酵素市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球诊断酵素市场规模、对比及成长率分析
  • 全球诊断酵素市场表现：规模与成长，2020-2025年
  • 全球诊断酵素市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依产品类型
  • 碳水化合物降解酶、聚合酵素和核酸酶、蛋白酶以及其他产物类型
  • 按来源
  • 动物、微生物、植物
  • 透过使用
  • 生物催化、诊断、製药、研究和生物技术
  • 按类型细分：碳水化合物降解酶
  • 淀粉酶、纤维素酶、乳糖酶、Glucosidase
  • 按类型细分：聚合酵素和核酸酶
  • DNA聚合酵素、RNA聚合酵素、限制性内切酶、核酸外切酶
  • 按类型细分：蛋白酶
  • 丝胺酸蛋白酶、半胱氨酸蛋白酶、金属蛋白酶、天门冬胺酸蛋白酶
  • 按类型细分：其他产品类型
  • 氧化还原酶、转移酶、解离酶、水解酵素

第十章 区域与国家分析

  • 全球诊断酵素市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球诊断酵素市场：依国家、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 诊断酵素市场：竞争格局及市场占有率（2024年）
  • 诊断酵素市场：公司估值矩阵
  • 诊断酵素市场：公司概况
    • Sanofi SA
    • Advanced Enzymes Technologies
    • Aldevron LLC
    • Amano Enzymes Inc.
    • Codexis Inc.

第37章：其他领先和创新企业

  • EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年诊断酵素市场：提供新机会的国家
  • 2030年诊断酵素市场：充满新机会的细分市场
  • 2030年诊断酵素市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: PH4MDENZ02_G26Q1

Diagnostic enzymes are enzymes that are used either directly or as components of assay systems to identify the presence or absence of various compounds, helping to detect, diagnose, or predict the progression of disease conditions. They are widely applied in diagnostics due to their high substrate specificity and measurable activity, even in the presence of other proteins.

The primary product types in the diagnostic enzymes market include carbohydrases, polymerases, nucleases, proteases, and others. Carbohydrases are a class of enzymes, such as amylase, that facilitate the breakdown or synthesis of carbohydrates, including disaccharides. These enzymes are sourced from animals, microorganisms, and plants and are used across applications such as biocatalysts, diagnostics, pharmaceuticals, research, and biotechnology.

Tariffs have impacted the diagnostic enzyme market by raising costs for imported high-purity enzymes, reagents, and laboratory equipment, particularly affecting segments like polymerases, nucleases, and proteases. Regions such as North America and Europe, which depend heavily on imports from Asia-Pacific manufacturing hubs, are most affected. While tariffs have increased operational costs and slowed procurement, they have also incentivized local enzyme production, development of cost-effective alternatives, and innovation in diagnostic assay technologies.

The diagnostic enzyme market research report is one of a series of new reports from The Business Research Company that provides diagnostic enzyme market statistics, including diagnostic enzyme industry global market size, regional shares, competitors with a diagnostic enzyme market share, detailed diagnostic enzyme market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic enzyme industry. This diagnostic enzyme market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diagnostic enzyme market size has grown strongly in recent years. It will grow from $4.49 billion in 2025 to $4.75 billion in 2026 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to limited availability of high-purity diagnostic enzymes, reliance on traditional assay methods, increasing prevalence of chronic diseases, growing biotechnology and research initiatives, rising awareness of enzyme-based diagnostics.

The diagnostic enzyme market size is expected to see strong growth in the next few years. It will grow to $6.39 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to development of advanced enzyme engineering techniques, integration of diagnostics with digital health platforms, rising adoption of point-of-care testing, expansion of pharmaceutical and biotech R&D, increasing government and private funding for diagnostic innovations. Major trends in the forecast period include rising adoption of enzyme-based diagnostic kits, growth in personalized medicine and biomarker detection, expansion of research and biotechnology applications, increasing demand for high-specificity and sensitive enzymes, integration of enzyme diagnostics in point-of-care testing.

The increasing prevalence of chronic diseases is expected to drive the growth of the diagnostic enzymes market in the coming years. Chronic diseases are long-term health conditions that persist for three months or longer. Diagnostic enzymes play a critical role in the diagnosis and ongoing monitoring of chronic diseases and other medical conditions by enabling healthcare professionals to evaluate disease severity, track treatment effectiveness, and make informed adjustments to care plans. For example, in January 2023, according to the National Library of Medicine, a US-based agency, the population in the United States aged 50 years and older with at least one chronic condition is projected to rise by 99.5%, increasing from 71.522 million to 142.66 million by 2050. Therefore, the growing burden of chronic diseases is contributing to the expansion of the diagnostic enzymes market.

Major companies operating in the diagnostic enzymes market are increasingly emphasizing technological innovations, such as digital PCR platforms, to address the rising demand for highly sensitive and absolute quantification in clinical diagnostics, particularly in oncology and infectious disease testing. Digital PCR (dPCR) is a technique that divides a sample into thousands of nanoliter-scale reactions, enabling precise absolute quantification of target nucleic acids without the need for standard curves. Unlike traditional quantitative PCR, which relies on reference standards and may lack accuracy at low target levels, dPCR delivers greater precision. For instance, in September 2024, QIAGEN N.V., a Germany-based biotechnology company, launched the QIAcuityDx Digital PCR System, a clinical-grade dPCR platform. This system combines partitioning, thermocycling, and imaging within a single automated device, allowing accurate DNA and RNA quantification for applications such as liquid biopsy-based cancer monitoring. The platform features IVDR certification in Europe, 510(k) exemption in the United States, intuitive software, flexible scheduling, and support for companion diagnostic development through the GeneGlobe platform. The QIAcuityDx system improves laboratory efficiency by reducing manual handling while delivering consistent and reliable results, even for low-abundance targets.

In January 2023, SD Biosensor Inc., a South Korea-based provider of in vitro diagnostic platforms and rapid testing systems, together with its partner SJL Services Private Limited, acquired Meridian Bioscience Inc. for $1.53 billion. Through this acquisition, SD Biosensor sought to accelerate its expansion into the US in vitro diagnostics market by leveraging Meridian Bioscience's established regulatory expertise and distribution network. Meridian Bioscience Inc. is a US-based company specializing in diagnostic testing solutions and life-science raw materials.

Major companies operating in the diagnostic enzyme market are Sanofi S.A., Advanced Enzymes Technologies, Aldevron LLC, Amano Enzymes Inc., Codexis Inc., EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson, AbbVie Inc., Amgen Inc., Biogen Inc., Gilead Sciences Inc., Regeneron Pharmaceuticals Inc.

North America was the largest region in the enzymes market in 2025. Middle East is expected to be the fastest-growing region in the diagnostic enzyme market report during the forecast period. The regions covered in the diagnostic enzyme market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the diagnostic enzyme market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The diagnostic enzymes market consists of sales of acid phosphatase, alanine aminotransferase, cholinesterase, and aspartate aminotransferase. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in the diagnostic enzymes market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diagnostic Enzyme Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses diagnostic enzyme market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diagnostic enzyme ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The diagnostic enzyme market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Carbohydrases; Polymerases And Nucleases; Protease; Other Product Types
  • 2) By Source: Animals; Microorganisms; Plants
  • 3) By Application: Biocatalysts; Diagnostics; Pharmaceuticals; Research & Biotechnology
  • Subsegments:
  • 1) By Carbohydrases: Amylases; Cellulases; Lactases; Glucosidases
  • 2) By Polymerases And Nucleases: DNA Polymerases; RNA Polymerases; Restriction Endonucleases; Exonucleases
  • 3) By Protease: Serine Proteases; Cysteine Proteases; Metalloproteases; Aspartic Proteases
  • 4) By Other Product Types: Oxidoreductases; Transferases; Lyases; Hydrolases
  • Companies Mentioned: Sanofi S.A.; Advanced Enzymes Technologies; Aldevron LLC; Amano Enzymes Inc.; Codexis Inc.; EKF Diagnostic; Kaneka Eurogentec; Roche Holding AG; Sekisui Diagnostics LLC; Thermo Fisher Scientific Inc.; Charles River Laboratories; Biocatalysts; Merck & Co. Inc.; Chr. Hansen; Kerry Group; Dyadic International; Creative Enzymes; Pfizer Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; GlaxoSmithKline plc; Johnson & Johnson; AbbVie Inc.; Amgen Inc.; Biogen Inc.; Gilead Sciences Inc.; Regeneron Pharmaceuticals Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Diagnostic Enzyme Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Diagnostic Enzyme Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Diagnostic Enzyme Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Diagnostic Enzyme Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Enzyme-Based Diagnostic Kits
    • 4.2.2 Growth In Personalized Medicine And Biomarker Detection
    • 4.2.3 Expansion Of Research And Biotechnology Applications
    • 4.2.4 Increasing Demand For High-Specificity And Sensitive Enzymes
    • 4.2.5 Integration Of Enzyme Diagnostics In Point-Of-Care Testing

5. Diagnostic Enzyme Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Research Laboratories
  • 5.3 Biotechnology Companies
  • 5.4 Hospitals And Diagnostic Centers
  • 5.5 Academic And Clinical Research Institutions

6. Diagnostic Enzyme Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Diagnostic Enzyme Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Diagnostic Enzyme PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Diagnostic Enzyme Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Diagnostic Enzyme Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Diagnostic Enzyme Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Diagnostic Enzyme Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Diagnostic Enzyme Market Segmentation

  • 9.1. Global Diagnostic Enzyme Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carbohydrases, Polymerases And Nucleases, Protease, Other Product Types
  • 9.2. Global Diagnostic Enzyme Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Animals, Microorganisms, Plants
  • 9.3. Global Diagnostic Enzyme Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biocatalysts, Diagnostics, Pharmaceuticals, Research & Biotechnology
  • 9.4. Global Diagnostic Enzyme Market, Sub-Segmentation Of Carbohydrases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Amylases, Cellulases, Lactases, Glucosidases
  • 9.5. Global Diagnostic Enzyme Market, Sub-Segmentation Of Polymerases And Nucleases, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • DNA Polymerases, RNA Polymerases, Restriction Endonucleases, Exonucleases
  • 9.6. Global Diagnostic Enzyme Market, Sub-Segmentation Of Protease, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serine Proteases, Cysteine Proteases, Metalloproteases, Aspartic Proteases
  • 9.7. Global Diagnostic Enzyme Market, Sub-Segmentation Of Other Product Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oxidoreductases, Transferases, Lyases, Hydrolases

10. Diagnostic Enzyme Market Regional And Country Analysis

  • 10.1. Global Diagnostic Enzyme Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Diagnostic Enzyme Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Diagnostic Enzyme Market

  • 11.1. Asia-Pacific Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Diagnostic Enzyme Market

  • 12.1. China Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Diagnostic Enzyme Market

  • 13.1. India Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Diagnostic Enzyme Market

  • 14.1. Japan Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Diagnostic Enzyme Market

  • 15.1. Australia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Diagnostic Enzyme Market

  • 16.1. Indonesia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Diagnostic Enzyme Market

  • 17.1. South Korea Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Diagnostic Enzyme Market

  • 18.1. Taiwan Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Diagnostic Enzyme Market

  • 19.1. South East Asia Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Diagnostic Enzyme Market

  • 20.1. Western Europe Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Diagnostic Enzyme Market

  • 21.1. UK Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Diagnostic Enzyme Market

  • 22.1. Germany Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Diagnostic Enzyme Market

  • 23.1. France Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Diagnostic Enzyme Market

  • 24.1. Italy Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Diagnostic Enzyme Market

  • 25.1. Spain Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Diagnostic Enzyme Market

  • 26.1. Eastern Europe Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Diagnostic Enzyme Market

  • 27.1. Russia Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Diagnostic Enzyme Market

  • 28.1. North America Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Diagnostic Enzyme Market

  • 29.1. USA Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Diagnostic Enzyme Market

  • 30.1. Canada Diagnostic Enzyme Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Diagnostic Enzyme Market

  • 31.1. South America Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Diagnostic Enzyme Market

  • 32.1. Brazil Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Diagnostic Enzyme Market

  • 33.1. Middle East Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Diagnostic Enzyme Market

  • 34.1. Africa Diagnostic Enzyme Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Diagnostic Enzyme Market, Segmentation By Product Type, Segmentation By Source, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Diagnostic Enzyme Market Regulatory and Investment Landscape

36. Diagnostic Enzyme Market Competitive Landscape And Company Profiles

  • 36.1. Diagnostic Enzyme Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Diagnostic Enzyme Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Diagnostic Enzyme Market Company Profiles
    • 36.3.1. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Advanced Enzymes Technologies Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Aldevron LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Amano Enzymes Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Codexis Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Diagnostic Enzyme Market Other Major And Innovative Companies

  • EKF Diagnostic, Kaneka Eurogentec, Roche Holding AG, Sekisui Diagnostics LLC, Thermo Fisher Scientific Inc., Charles River Laboratories, Biocatalysts, Merck & Co. Inc., Chr. Hansen, Kerry Group, Dyadic International, Creative Enzymes, Pfizer Inc., Eli Lilly and Company, Bristol-Myers Squibb Company

38. Global Diagnostic Enzyme Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Diagnostic Enzyme Market

40. Diagnostic Enzyme Market High Potential Countries, Segments and Strategies

  • 40.1 Diagnostic Enzyme Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Diagnostic Enzyme Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Diagnostic Enzyme Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer